Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: An open label single arm phase II trial

OBJECTIVES: This multicenter phase II trial evaluated the safety and efficacy of pegylated liposomal doxorubicin (PLD) in place of conventional doxorubicin in standard RCHOP therapy for elderly patients with diffuse large B-cell lymphoma. METHODS: Patients ≥ 60 years of age who had stage II to IV di...

詳細記述

保存先:
書誌詳細
出版年:Clin Lymphoma Myeloma Leuk
主要な著者: Oki, Yasuhiro, Ewer, Michael S., Lenihan, Daniel J., Fisch, Michael J., Hagemeister, Fredrick B., Fanale, Michelle, Romaguera, Jorge, Pro, Barbara, Fowler, Nathan, Younes, Anas, Astrow, Alan B., Huang, Xuelin, Kwak, Larry W., Samaniego, Felipe, McLaughlin, Peter, Neelapu, Sattva S., Wang, Michael, Fayad, Luis E., Durand, Jean-Bernard, Rodriguez, M. Alma
フォーマット: Artigo
言語:Inglês
出版事項: 2014
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4344896/
https://ncbi.nlm.nih.gov/pubmed/25445468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2014.09.001
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料